Evidence map›Paper›PMID 21737172›Full record

ArticleDiabetes research and clinical practice2011

Development and initial validation of the barriers to diabetes adherence measure for adolescents.

Shelagh A Mulvaney, Korey K Hood, David G Schlundt, Chandra Y Osborn, Kevin B Johnson, Russell L Rothman, Kenneth A Wallston

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02530450 completednot on this map

iPro Continuous Glucose Monitor in Children With Poorly Controlled Diabetes: A 6-Month, Randomized, Interventional Pilot Study

TypeobservationalSponsorThe University of Texas Health Science Center at San AntonioRan2011 to 2013Enrolled30ConditionsType 1 Diabetes MellitusArmscontinuous glucose monitoring (CGM)
NCT02828995 completednot on this mapstarted 2016, after this paper: background citation

Evaluating the Influence of Diabetes Stigma on Medication Adherence

TypeobservationalSponsorVanderbilt University Medical CenterRan2016 to 2017Enrolled508ConditionsDiabetes MellitusArmsComprehensive Diabetes Stigma Survey
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shelagh A MulvaneyVanderbilt University Medical Center, School of Nursing, Nashville, TN 37240, USA. shelagh.mulvaney@vanderbilt.edu
Korey K Hood
David G Schlundt
Chandra Y Osborn
Kevin B Johnson
Russell L Rothman
Kenneth A Wallston
Vanderbilt University Medical Center · USCincinnati Children's Hospital Medical Center · USVanderbilt University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 1986 to 2011
$28.1M
Vanderbilt Center for Diabetes Translation ResearchP30DK092986 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROTHMAN, RUSSELL L. · 2011 to 2020
$6.7M
Adolescent Self-Management of Diabetes: An InterventionR21DK070026 · NIDDK · VANDERBILT UNIVERSITY · PI MULVANEY, SHELAGH A · 2006 to 2007
$416k
NCRR NIH HHS 1 UL1 RR024975NCRR NIH HHS UL1 RR024975NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK092986NIDDK NIH HHS P60 DK020593NIDDK NIH HHS P60DK020593NIDDK NIH HHS R21 DK070026
6 · The paper itself

Abstract

aimsThe purpose of this study was to develop a measure of psychosocial barriers to adherence in adolescents with type 1 diabetes (T1D) and examine relationships to patient characteristics, adherence, and hemoglobin A1C (A1C).

methodsBarriers to diabetes adherence (BDA) items were generated by researchers, clinicians, and patients. Adolescents aged 12-17 with T1D completed the BDA and an adherence measure. Hemoglobin A1C was obtained through medical chart review.

resultsFactor analysis from 123 adolescents resulted in a 21-item, five-component solution that accounted for 64.5% of the variance. The components were stress and burnout, time pressure and planning, social support, parental autonomy support, and stigma. The BDA total and subscales were internally consistent. The BDA total and some components were associated with adherence and A1C. The BDA was the only predictor of A1C compared to demographic, clinical, and adherence variables (F 6.17, p<.05). Subjects with higher A1C (>8.5) showed a higher level of barriers (F 15.20, p<.001) and a differential profile of barriers (F 5.75, p<.05).

conclusionsThe BDA may be useful in research and clinical settings as a compliment to adherence measures and to tailor educational programs. Additional research is necessary to establish test-retest reliability and discriminant validity.

Indexed as

AdolescentChildDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansMalePatient ComplianceSurveys and QuestionnairesGlycated Hemoglobin

Identifiers

PMID21737172
PMCPMC3200487
OpenAlexW2162657141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.